Compare Stocks

Cellcom Israel Ltd. operates and maintains a cellular mobile telephone system in Israel. It operates in two segments, Cellular and Fixed-line. The company offers cellular communications services, such as basic cellular telephony services comprising voice mail, cellular fax, call waiting, call forwarding, caller identification, and conference calling; text and multimedia messaging; and cellular content and data services. It also provides international roaming services; value-added services, such as short message and multimedia messaging; cloud backup; and content services, including Cellcom Volume music, Cellcom TV, and other applications. In addition, the company sells handsets, tablets, streamers, smart watches, and home security cameras, as well as offers repair services. Further, it provides internet infrastructure and connectivity services, over-the-top TV services, international long distance services, and landline telephony and transmission services; transmission and data services through fiber-optic infrastructure and complementary microwave links; IP switchboard services; and cloud services and data protection products, as well as operates and manages business telecommunication systems to selected business customers and telecommunications operators. As of December 31, 2019, the company had approximately 10.6 million cellular subscribers. Cellcom Israel Ltd. was founded in 1994 and is headquartered in Netanya, Israel.

GP Strategies Corp. provides training, e-Learning solutions, management consulting and engineering services. It operates through the following Geographic Segments: North America, EMEA and Emerging Markets (Latin America and Asia Pacific countries). It provides Workforce Transformation Services into three primary solution sets: Organizational Performance Solutions (OPS), Technical Performance Solutions (TPS) and Automotive Performance Solutions (APS). The company was founded in 1959 and is headquartered in Columbia, MD.

ShangPharma Corporation (ShangPharma) is a China-based holding company. The Company is a pharmaceutical and biotechnology research and development (R&D) outsourcing company. It provides a range of high-quality, integrated services across the drug discovery and development process to international and Chinese pharmaceutical and biotechnology companies. Its services consist of discovery chemistry, discovery biology and preclinical development, pharmaceutical development and biologics services. It has a diversified and loyal global customer base. In March 2013, the Company completed the merger contemplated by the previously announced Agreement and Plan of Merger (the Merger Agreement), by and among the Company, ShangPharma Holdings Limited (Holdings), ShangPharma Parent Limited (Parent) and ShangPharma Merger Sub Limited (Merger Sub). As a result of the merger, the Company became a wholly owned subsidiary of Parent.

Special Opportunities Fund, Inc. is a close-ended balanced fund of funds launched and managed by Bulldog Investors, LLC. It invests in close-ended funds investing in public equity and fixed income markets. The fund employs a combination of value, opportunistic and special situations strategies to make its investments. It benchmarks the performance of its portfolio against the S&P 500 Index. The fund was previously known as Insured Municipal Income Fund, Inc. Special Opportunities Fund, Inc. was formed on February 18, 1993 and is domiciled in the United States.